Tyra Biosciences

Filed a patent for "fgfr3 inhibitor compounds" on Mon, December 19, 2022

Filed a patent for "indazole compounds" on Thu, December 22, 2022

Filed a patent for "indazole compounds as kinase inhibitors" on Thu, June 27, 2024

Filed a patent for "indazole compounds" on Wed, June 29, 2022

Filed a patent for "indazole compounds" on Mon, December 19, 2022

Filed a patent for "indazole compounds as kinase inhibitors" on Thu, April 4, 2024

Filed a patent for "aminopyrimidine compounds and methods of their use" on Thu, June 13, 2024

Filed a patent for "indazole compounds" on Fri, December 22, 2023

Filed a patent for "therapies with ppar agonists and fgfr4 inhibitors" on Thu, May 19, 2022

Filed a patent for "indazole compounds" on Thu, April 13, 2023

Filed a patent for "aminopyrimidine compounds" on Thu, April 13, 2023

Filed a patent for "polymorphic compounds and uses thereof" on Wed, June 29, 2022

Filed a patent for "methods of treating solid tumors having activating fgfr3 gene alterations" on Tue, August 30, 2022

Filed a patent for "therapies with ppar agonists and fgfr4 inhibitors" on Mon, October 3, 2022